This group reported that the triple combination (anti-PD1, localized radiation and NBTXR3) reduced growth of irradiated and unirradiated tumors in 344SQP anti-PD1-sensitive lung cancer cells and 344SQR anti-PD1-resistant lung cancer cells (Hu et al., 2021c). Here, PDCD1 is linked to lung cancer.